Skip to main content

Symposium 2014: Limits to Tolerance of Increased RAS Signaling in Cancer

Symposium 2014: Limits to Tolerance of Increased RAS Signaling in Cancer

Dr. Kevin Shannon, UCSF, describes how dominant oncogenes, Notch and KRAS, are down-regulated in drug-resistant leukemias.